denosumab (prolia) Report issue

Biologics mAb Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$199.7793 - $372.2060

VA Big4

$845.4200 - $1407.2940

VA FSS

$1156.6900 - $2009.2555

NADAC

$1307.4975

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
denosumab 120 mg / 1.7 mL (1.7 mL INJECTION) $372.2060 AUS PBS generic
  • Xgeva (1)
    		•  Amgen Australia Pty Limited
    denosumab 120 mg / 1.7 mL (1.7 mL INJECTION) $1407.2940 VA Big4
  • XGEVA (1.2)
    		•  Amgen USA, Inc.
    denosumab 120 mg / 1.7 mL (1.7 mL INJECTION) $2009.2555 VA FSS
  • XGEVA (1.2)
    		•  Amgen USA, Inc.
    denosumab 60 mg / 1 mL (1 mL INJECTION) $199.7793 AUS PBS generic
  • Prolia (1)
    		•  Amgen Australia Pty Limited
    denosumab 60 mg / 1 mL (1 mL INJECTION) $845.4200 VA Big4
  • Prolia (1)
    		•  Amgen USA, Inc.
    denosumab 60 mg / 1 mL (1 mL INJECTION) $1156.6900 VA FSS
  • Prolia (1)
    		•  Amgen USA, Inc.
    denosumab 60 mg / 1 mL (1 mL INJECTION) $1307.4975 NADAC brand
  • Prolia (1)
    		•  Amgen Inc

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue